glp 1 and migraine Could GLP-1s prevent migraine? A new study of 22,000 chronic patients suggests...maybe. Over 12 months, GLP-1 users vs topiramate users had: >10% fewer ED visits >14% fewer hospitalizations >48% less likely Headaches from GLP-1 Injections -

Metabolomics and its application to studying metal toxicity

It enhances atherosclerosis, promotes thrombosis potential, vascular inflammation and inflammasome activation [17]

Study methods and models vary by institution and protocol

This makes it crucial to minimize or avoid using NSAIDs and other nephrotoxic agents in patients with SLE and established CKD, with special care on dose adjustment for several agents commonly used for nephro-protection

Diagnosing PA: the commonest non-nutritional cause of vitamin B deficiency Given how NICE guidelines are used in practice, we find that the guidelines lack specific advice on the clinical scenarios in which practitioners should suspect AIG and PA

Muscle preservation usually requires adequate protein, resistance training, enough total nutrition, hydration, and medical monitoring when needed